Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer
Phase 2 Unknown
138 enrolled
Liposomal Doxorubicin in Treating Patients With Advanced Stomach Cancer
Phase 2 Unknown
Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma
Phase 2 Unknown
57 enrolled
Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
Phase 2 Unknown
73 enrolled
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Phase 2 Unknown
25 enrolled
Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma
Phase 2 Unknown
56 enrolled
VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia
Phase 2 Unknown
85 enrolled
Bortezomib and Dexamethasone in Treating Patients With Multiple Myeloma That Has Relapsed or Has Not Responded to Treatment
Phase 2 Unknown
30 enrolled
Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma
Phase 2 Unknown
50 enrolled
Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma
Phase 2 Unknown
200 enrolled
Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas
Phase 2 Unknown
80 enrolled
Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer
Phase 2 Unknown
20 enrolled
Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer
Phase 2 Unknown
20 enrolled
Capecitabine, Panitumumab, and Radiation Therapy With or Without Irinotecan Hydrochloride in Treating Patients Undergoing Surgery for Localized Rectal Cancer
Phase 2 Unknown
54 enrolled
Combination Chemotherapy in Treating Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase 2 Unknown
180 enrolled
Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia
Phase 2 Unknown
52 enrolled
Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin Lymphoma
Phase 2 Unknown
70 enrolled
Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer
Phase 2 Unknown
40 enrolled
Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma or Other B-cell Cancers
Phase 2 Unknown
10 enrolled
High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Lung Cancer
Phase 2 Unknown
30 enrolled
Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
Phase 2 Unknown
25 enrolled
Irinotecan in Treating Patients With Stage IV or Recurrent Soft Tissue Sarcoma
Phase 2 Unknown
27 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
Phase 2 Unknown
Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
Phase 2 Unknown
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Phase 2 Unknown
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
Phase 2 Unknown
52 enrolled
Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer
Phase 2 Unknown
T138067 in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer That Has Not Responded to Previous Chemotherapy
Phase 2 Unknown
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
Phase 2 Unknown
Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer
Phase 2 Unknown
Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma
Phase 2 Unknown
Lometrexol Plus Folic Acid in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Unknown
Rosiglitazone in Treating Patients With Locoregionally Extensive or Metastatic Thyroid Cancer
Phase 2 Unknown
25 enrolled
Cyclosporine and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Phase 2 Unknown
25 enrolled
Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer
Phase 2 Unknown
14 enrolled
Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer
Phase 2 Unknown
14 enrolled
Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer
Phase 2 Unknown
100 enrolled
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
Phase 2 Unknown
26 enrolled
Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer
Phase 2 Unknown
17 enrolled
Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas
Phase 2 Unknown
150 enrolled
Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
Phase 2 Unknown
41 enrolled
Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
Phase 2 Unknown
75 enrolled
Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus
Phase 2 Unknown
Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia
Phase 2 Unknown
Docetaxel and Vinorelbine Plus Filgrastim in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Phase 2 Unknown
ZD0473 in Treating Patients With Progressive or Relapsed Non-Small Lung Cancer
Phase 2 Unknown
Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer
Phase 2 Unknown
Epratuzumab in Treating Patients With Non-Hodgkin's Lymphoma
Phase 2 Unknown
High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2
Phase 2 Unknown